龍佰集團(002601.SZ):擬投資20億元建年產15萬噸電子級磷酸鐵鋰項目
格隆匯1月17日丨龍佰集團(002601.SZ)公佈,公司於2022年1月17日召開的公司第七屆董事會第三十一次會議審議通過了《關於投資建設年產15萬噸電子級磷酸鐵鋰項目的議案》,為抓住新能源磷酸鐵鋰電池的發展機遇,公司控股子公司湖北佰利萬潤新能源有限公司擬投資建設年產15萬噸電子級磷酸鐵鋰項目,項目總投資20億元。
該項目將利用公司鈦白副產品,並結合公司在粉體材料研發及生產上掌握的經驗,持續在產業化中落實“大化工”和“低成本”兩大基本要求,製備高附加值的磷酸鐵材料,進一步生產磷酸鐵鋰,有利於公司形成更加完整的產業體系,積極推進公司融入新能源材料生產製造供應鏈,增強公司綜合競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.